New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
16:10 EDTIARTIntegra LifeSciences receives warning letter from FDA
Integra LifeSciences Holdings announced that on February 14 it received a warning letter from the FDA related to quality systems issues at its manufacturing facility located in Aņasco, Puerto Rico. The letter resulted from an inspection conducted at that facility during October and November 2012. The Company has provided certain additional information relating to the matters set forth in this press release, as well as a copy of the warning letter as an exhibit in a Current Report on Form 8-K filed concurrently with the issuance of this press release. The warning letter cites concerns relating to process validations, corrective and preventative actions, and document controls. Integra believes that it has already substantially remediated the issues addressed in the warning letter, and is in the process of having third-party consultants assess its procedures and processes to ensure that products are manufactured in accordance with applicable regulations, as recommended by FDA.
News For IART From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
06:57 EDTIARTIntegra LifeSciences to host conference call
Subscribe for More Information
June 28, 2015
12:28 EDTIARTIntegra LifeSciences to acquire TEI for $312M
Integra LifeSciences, TEI Biosciences, and TEI Medical announced a definitive agreement under which Integra will acquire all of the outstanding shares of TEI Biosciences and TEI Medical for $312M cash at closing. The companies expect to complete this transaction during Q3. Preliminarily, Integra expects the acquired revenue to increase high single digits in the first full year after closing. Integra will provide further guidance, including expectations for 2015 financial performance, when it reports Q2 results in late July. "Upon closing, we expect this deal to be immediately accretive to our adjusted EBITDA and operating margins, and slightly accretive to our adjusted EPS, including the effects of any financing transactions that may close subsequent to the closing of the TEI acquisition," said Integra CFO Glenn Coleman. Integra also noted that the acquisition will expand its sales force with the addition of roughly 125 sales reps and managers.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use